1988 - Fellow of the American Psychological Association (APA)
The scientist’s investigation covers issues in Placebo, Psychiatry, Internal medicine, Expectancy theory and Randomized controlled trial. His work deals with themes such as Anesthesia, Clinical trial, Conditioning, Acupuncture and Pill, which intersect with Placebo. His Psychiatry study which covers Meta-analysis that intersects with Adverse effect, Anxiety disorder, Reuptake inhibitor and Relative risk.
His biological study spans a wide range of topics, including Zaleplon, Sleep onset and Eszopiclone. His Expectancy theory research is multidisciplinary, relying on both Hypnosis and Brain mapping. His research integrates issues of Psychotherapist, Developmental psychology, Personality, Clinical psychology and Sexual dysfunction in his study of Hypnosis.
Irving Kirsch mainly investigates Placebo, Hypnosis, Expectancy theory, Psychotherapist and Clinical psychology. His Placebo research is multidisciplinary, incorporating elements of Anesthesia, Internal medicine, Clinical trial, Randomized controlled trial and Psychiatry. Irving Kirsch interconnects Physical therapy and Pill in the investigation of issues within Randomized controlled trial.
The various areas that Irving Kirsch examines in his Hypnosis study include Developmental psychology, Cognitive psychology, Suggestibility and Hypnotic. He works mostly in the field of Expectancy theory, limiting it down to concerns involving Cognition and, occasionally, Classical conditioning. His Psychotherapist study combines topics from a wide range of disciplines, such as Cognitive therapy and Altered state.
Placebo, Psychiatry, Randomized controlled trial, Internal medicine and Clinical trial are his primary areas of study. His research in Placebo intersects with topics in Expectancy theory, Anesthesia, Physical therapy and Acupuncture. His study in Expectancy theory is interdisciplinary in nature, drawing from both Stimulus and Hypnosis.
His research investigates the connection between Psychiatry and topics such as Clinical psychology that intersect with problems in Anxiety, Neuroticism and Psychotherapist. His Internal medicine study combines topics in areas such as Gastroenterology, Systematic review and Regression toward the mean. His studies deal with areas such as Psychological intervention, Treatment Effectiveness Evaluation and Drug as well as Clinical trial.
His primary areas of study are Placebo, Randomized controlled trial, Psychiatry, Anesthesia and Acupuncture. His Placebo study integrates concerns from other disciplines, such as Expectancy theory, Internal medicine, Conditioning and Physical therapy. Irving Kirsch combines subjects such as Placebo treatment, Anxiety disorder, Anxiety, Meta-analysis and Migraine with his study of Randomized controlled trial.
Irving Kirsch has included themes like Adverse effect and Clinical trial in his Psychiatry study. The Anesthesia study combines topics in areas such as Pill and Drug labeling. His work carried out in the field of Acupuncture brings together such families of science as Gastroenterology, Irritable bowel syndrome, Abdominal pain and Analgesic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
Irving Kirsch;Brett J Deacon;Tania B Huedo-Medina;Alan Scoboria.
PLOS Medicine (2008)
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Ted J Kaptchuk;John M Kelley;Lisa A Conboy;Roger B Davis.
BMJ (2008)
Response expectancy as a determinant of experience and behavior.
Irving Kirsch.
American Psychologist (1985)
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Ted Jack Kaptchuk;Ted Jack Kaptchuk;Elizabeth Friedlander;John Michael Kelley;John Michael Kelley;M. Norma Sanchez.
PLOS ONE (2010)
The Emperor's New Drugs: Exploding the Antidepressant Myth
Irving Kirsch.
(2009)
Hypnosis as an adjunct to cognitive-behavioral psychotherapy: A meta-analysis.
Irving Kirsch;Guy Montgomery;Guy Sapirstein.
Journal of Consulting and Clinical Psychology (1995)
Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication
Irving Kirsch;Guy Sapirstein.
Prevention & Treatment (1998)
An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm
Donald D Price;Leonard S Milling;Irving Kirsch;Ann Duff.
Pain (1999)
Chiral symmetry breaking and pions in nonsupersymmetric gauge / gravity duals
J. Babington;J. Erdmenger;Nick J. Evans;Z. Guralnik.
Physical Review D (2004)
Classical conditioning and the placebo effect
Guy H Montgomery;Irving Kirsch.
Pain (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Beth Israel Deaconess Medical Center
Binghamton University
Harvard University
Sapienza University of Rome
Harvard University
Harvard University
Icahn School of Medicine at Mount Sinai
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Télécom SudParis
National Tsing Hua University
North China University of Science and Technology
University of Windsor
Spanish National Research Council
Brigham and Women's Hospital
Michigan State University
Johns Hopkins University School of Medicine
GlaxoSmithKline (United Kingdom)
Indian Council of Medical Research
University of Utah
German Aerospace Center
University of Minnesota
University of Rochester
University of Bristol
University of Kentucky